NL-OMON28367招募中不适用
Medication Actions to Reduce hospital admissions through a collaboration of Community and Hospital pharmacists
1. OLVG: dr. Fatma Karapinar; prof. dr. Patricia van den Bemt; dr. B. van den Bemt and Elien Uitvlugt (PhD candidate) 2. Amsterdam UMC (VUmc): dr. Jacqueline Hugtenburg; prof. dr. E.L. Swart; dr. Pierre Bet and Selma En-nasery – de heer (PhD candidate)0 个研究点目标入组 390 人开始时间: 待定最近更新:
试验速览
- 阶段
- 不适用
- 状态
- 招募中
- 发起方
- 入组人数
- 390
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •Patients aged 18 years and older, using 5 or more chronic medicines, discharged from the hospital (departments of surgery, internal medicine, cardiology), with 1 or more changes in their chronic medication
排除标准
- •Patients discharged to a nursing home, patients with a life expectancy shorter than 6 months, patients with a language barriere, patients not willing or unable due physical/mental constraints to participate in this study, patients' community not enrolled in the study
研究者
相似试验
已完成
不适用
Reduction of potentially inappropriate medication in the elderypotentially inappropriate medication in the elderly (no specific disease or condition necessary for study inclucion)DRKS00003610Ruhr-Universität Bochum1,275
已完成
不适用
A pilot study of an outpatient clinic to reduce hospital readmission rates in alcohol-dependent patientsMental and Behavioural DisordersMental and behavioural disorders due to use of alcoholAlcohol dependenceISRCTN81371128King's College Hospital NHS Foundation Trust (UK)200
已完成
不适用
Multifactorial day hospital intervention to reduce falls in high risk older people in primary careFallsInjury, Occupational Diseases, PoisoningISRCTN46584556ottingham City Hospital (UK)400
已完成
Unknown
the effect of hospital readmission reduction program on heart failure patientsHeart failureIRCT20230717058816N1Mashhad University of Medical Sciences76
进行中（未招募）
不适用
Symptom reduction in hospitalized patients suffering from symptomatic non-erosive or erosive gastroesophageal reflux disease treated with pantoprazole 20 or 40 mg o.d. for 7 days - PROFISymptomatic non-erosive reflux disease (NERD) or erosive gastroesophageal reflux disease (GERD)MedDRA version: 8.1Level: LLTClassification code 10017885Term: Gastrooesophageal reflux diseaseEUCTR2005-004856-11-DEALTANA Pharma AG350